Skip to main content

There’s something almost remarkable about watching a decades-old debate over a vaccine ingredient suddenly shape the fates of children in Mali, Chad, and South Sudan. The ingredient in question has been used since the 1930s. The science examining it spans countless studies. And the verdict – from every major health authority on earth – has been the same for years. Yet in 2026, that ingredient is at the center of one of the most consequential policy fights in global public health.

If you’ve heard the word “thimerosal” lately, you’re not alone. The word is everywhere: in congressional hearings, in international funding negotiations, and on social media feeds where concern about what goes into vaccines has never been louder. For parents who want to make informed decisions about their family’s health, and for anyone who follows public health policy, the debate raises real questions worth understanding clearly. What exactly is thimerosal? What does the evidence actually say? And why does a disagreement over a compound used in a small fraction of the global vaccine supply have the potential to derail vaccination programs protecting tens of millions of children?

Those are the questions worth unpacking – starting with the science, and then the politics that are pushing against it.

What Thimerosal Actually Is

Thimerosal is a mercury-containing preservative that has been used in small amounts in some multidose vaccine vials since the 1930s to prevent microbial contamination. The “multidose vial” part matters here. When health workers draw multiple doses from a single bottle over the course of hours or days, there’s a real risk that bacteria or fungi can enter the vial. Thimerosal is added to those vials to prevent the growth of germs like bacteria and fungi.

The mercury angle is where fear tends to creep in, and it’s worth being precise about the chemistry. The two types of mercury to which people may be exposed, methylmercury and ethylmercury, are very different. Most people have heard warnings about methylmercury, the kind found in large fish like tuna and swordfish. The mercury in thimerosal is ethylmercury, which is rapidly excreted from the body and is not harmful at the levels present in vaccines. Methylmercury is a more dangerous type and can accumulate in the body when people are exposed through the environment or certain foods like fish.

Put simply: the mercury in thimerosal clears your system rapidly. The mercury people are typically warned about in fish does not. Ethylmercury is different from methylmercury, the type found in certain fish. Ethylmercury is broken down and cleared from the body much more quickly than methylmercury, making it less likely to build up and cause health problems.

What the Science Says

The body of research on thimerosal is not small, and it does not leave much room for ambiguity. The scientific evidence collected over the past 20 or more years does not show any evidence of harm, including serious neurodevelopmental disorders, from use of thimerosal in vaccines. That finding comes from the FDA, which maintains a comprehensive review of the literature.

The National Academy of Medicine – formerly the Institute of Medicine – reviewed more than 200 studies and found that the evidence favored rejection of a causal relationship between thimerosal-containing vaccines and autism. Large epidemiologic studies in the United States and internationally reached the same conclusion. When thimerosal was removed from nearly all routine childhood vaccines in the United States more than two decades ago, a precautionary step taken to maintain public confidence rather than because of demonstrated harm, autism rates continued to rise, further undercutting claims of causation.

That last point is critical. If thimerosal were causing autism, removing it from childhood vaccines should have bent the curve downward. It didn’t. The CDC states plainly that research does not show any link between thimerosal in vaccines and autism, and that even after thimerosal was removed from almost all childhood vaccines, autism rates continued to increase, which is the opposite of what would be expected if thimerosal caused autism.

Thimerosal is an extensively studied preservative used in a small percentage of multidose vials of influenza vaccine administered in the US, and it has not been in any routine childhood vaccines since the early 2000s. In the most recent US flu season on record, research from Truveta found that 96% of administered influenza vaccines did not contain thimerosal. The ingredient was already almost entirely gone from American medicine before any policy intervention.

How This Became a Federal Policy Fight

The scientific consensus never went away. But the politics around thimerosal have escalated dramatically since HHS Secretary Robert F. Kennedy Jr. took office in early 2025.

Kennedy’s concern about thimerosal is not new. In 2005, Kennedy wrote an article co-published by Rolling Stone and Salon that alleged leading health agencies, including the CDC and FDA, had colluded with vaccine manufacturers to conceal a study that found thimerosal may have caused autism in thousands of kids. Continued research found no link between thimerosal and autism. Kennedy’s article was removed from Rolling Stone, and Salon retracted it in 2011.

That history makes his 2025 and 2026 actions at HHS particularly significant. In June 2025, Kennedy fired all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP), the body that shapes the nation’s vaccine schedule, and replaced them with a smaller panel that included several people with documented anti-vaccine views. A three-part vote on thimerosal in multidose flu vaccines came after a presentation from Lyn Redwood, president emerita for the anti-vaccine group Children’s Health Defense, which was founded and previously chaired by Kennedy.

The new panel voted to recommend against flu vaccines containing thimerosal. The Department of Health and Human Services then officially removed the mercury-based preservative from all flu shots distributed in the US, even though there is no evidence of harm from the ingredient.

As one dissenting panelist, Dr. Cody Meissner, a professor of pediatrics at Dartmouth, pointed out, no study has ever indicated any harm from thimerosal, and the FDA had not removed the additive because there was no evidence of harm. He also warned that discouraging multidose vials could increase the cost of vaccination and limit access for some populations.

For a look at how this same vaccine policy shift is playing out with the military, the Pentagon’s recent decision to end the mandatory flu shot for troops reflects a parallel policy direction that public health experts are watching closely.

The Global Ripple Effect

The domestic policy fight over thimerosal might have remained a largely American story. Instead, it went global. The US government gave an ultimatum to the international group that helps provide vaccines to children in the world’s poorest countries. In a statement sent to NPR, the Department of Health and Human Services said that Gavi, the Vaccine Alliance must remove the ingredient thimerosal from its vaccines, or else the US would withhold future new funding.

Gavi, the Vaccine Alliance is one of the most consequential public health organizations on the planet. Since its inception in 2000, Gavi has helped immunize over 1.2 billion children and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower-income countries. In 2024 alone, vaccination programs in lower-income countries supported by Gavi saved at least 1.7 million lives, the highest number recorded in a single year.

The US ultimatum targets the roughly 14% of Gavi’s vaccine portfolio that uses thimerosal in multidose vials. Those vials aren’t a quirk of neglect or cost-cutting. They exist because of practical reality. High-income countries can afford single-dose vials, which are more expensive and more expensive to transport and store. But low-income countries have to maintain a cold chain and they don’t have the refrigerator space to store single-dose vials. Without thimerosal, multidose vials risk bacterial and fungal contamination. Without multidose vials, mass vaccination campaigns in remote or conflict-affected settings become dramatically harder to execute.

The demand has alarmed scientists working in global health. Gavin Yamey, Professor of Global Health and Public Policy at Duke University, said agreeing to the US demand “would be a massive setback for global vaccination and would impede kids from getting vaccinated.” He added that the shift could not be done suddenly, as it would require major changes to the entire manufacturing, supply, and delivery pipeline. Over two decades of research has shown thimerosal is safe.

The funding pressure compounds an already strained relationship. The US was once a major funder of Gavi. In June 2025, the Trump administration cut off more than a billion dollars previously promised to the group. According to reporting by Devex, the United States no longer has representation on Gavi’s 28-member board because of the stalled funding. And for the upcoming 2026 to 2030 strategic period, the US announced it was donating zero dollars to Gavi, meaning Gavi announced it would fall almost three billion dollars short of its budget aim of $11.9 billion.

Experts have expressed concern that the US position could plant seeds of doubt in other countries. Infectious disease experts generally do not think Kennedy currently has the clout to convince nations elsewhere to ban thimerosal, particularly because it plays an important role in safeguarding vaccines globally. But they worry that by pushing the suggestion that the preservative presents a risk in shots, despite peer-reviewed scientific studies that have found otherwise, Kennedy may erode vaccination rates in other parts of the globe.

Read More: Why Six Vaccines Are No Longer Routinely Recommended for Children

What to Make of All This

There are legitimate conversations to have about vaccine safety, transparency in public health institutions, and the interests of parents who want to understand what their children receive. Those conversations deserve honesty, which is exactly why the thimerosal debate is so frustrating for researchers and clinicians: the science is thorough, and the conclusions are clear.

Extensive research has found no link between thimerosal-containing vaccines and autism. Major scientific and public health organizations, including the FDA, the CDC, and the World Health Organization, continue to support the safety of vaccines that contain thimerosal. The American Academy of Pediatrics has stated plainly that extensive research proves thimerosal is a safe ingredient in vaccines, and it does not cause neurological problems or autism.

The practical consequences of the current policy direction fall hardest on children who have the least access to healthcare. Without continued support from the US and other donors, the world is at risk of dangerous backsliding in immunization coverage, meaning more zero-dose children, more disease outbreaks, more diseases crossing borders, and more children who never reach even their fifth birthday.

What This Means for You

If you’re a parent or caregiver, the most important thing to understand is that thimerosal is not in any vaccine routinely given to American children under six. Study after study has found no evidence that thimerosal causes autism or other harm. Since 2001, all vaccines routinely used for US children age six and younger have come in thimerosal-free formulas, including single-dose flu shots that account for the vast majority of influenza vaccinations.

If you’re concerned about a specific vaccine your child is receiving, the simplest step is to ask your doctor or pharmacist for the vaccine’s package insert, which lists all ingredients. That’s not fear – it’s informed consent, and it’s always reasonable to ask.

For adults who want to engage with the broader policy debate, the best tool is understanding the difference between genuine safety questions and political arguments dressed up as scientific ones. Thimerosal’s safety record has been examined rigorously, repeatedly, and internationally. The ongoing campaign against it is not driven by new evidence. It is a case study in how ideology, not evidence, is driving federal health leadership. Staying grounded in what the data actually shows is the most powerful thing any informed reader can do when the noise gets loud.

Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.

AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.

Read More: Could a Single ‘Vaccine-Like’ Shot Treat Anxiety? Early Research Shows Promise